Department of Health Review of Life Savings Drugs Program medicines Mucopolysaccharidosis Type VI (MPS VI) Final Review Protocol

  • Stathis, S. (Advisor)
  • Lisa R. Fodero (Advisor)
  • Nerissa Soh (Advisor)
  • Rob Zebara (Advisor)
  • Katrin Schultz (Advisor)
  • Justine Biggs (Advisor)
  • Michael Ortiz (Advisor)

    Activity: End user engagement and expertise › Advisory position

    Period2019
    Work forDepartment of Health and Aged Care, Australian Government